Strategikon Announces Clinical Maestro 2.4
Strategikon Pharma announced a major update to their Clinical Maestro platform including features that target clinical trial planning and sourcing. This release, Clinical Maestro CORETM, focuses on expanding the ease of use and flexibility for Contract Research Organizations and other clinical service providers who need to quickly create accurate bids.
Clinical Maestro CORE is a configurable, cloud-based SaaS solution combining clinical study and services assumptions with complex costing algorithms that aim to produce clinical study budgets faster and more reliably than traditional Excel-based methods.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
